Improving neuron health in Parkinson's disease by enhancing cell cleanup processes
Rescuing ⍺-synuclein toxicity through neuron-specific enhancement of autophagy
This study is looking at how certain brain cells can help clear out harmful proteins related to Parkinson's disease, with the hope of finding new ways to protect brain cells and improve life for people living with the condition.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11113925 on NIH RePORTER |
What this research studies
This research focuses on understanding how specific brain cells can better manage toxic proteins associated with Parkinson's disease. By enhancing the natural cleanup process called autophagy, the study aims to reduce the harmful effects of a protein known as alpha-synuclein, which is linked to the progression of the disease. The principal investigator, who has extensive training in neurology and neuroscience, will utilize advanced techniques such as CRISPR gene editing and high-throughput screening to explore these mechanisms. The ultimate goal is to develop new strategies that could protect neurons and improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Parkinson's disease who are experiencing symptoms related to the condition.
Not a fit: Patients with other neurodegenerative disorders or those without a diagnosis of Parkinson's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that slow down or prevent the progression of Parkinson's disease.
How similar studies have performed: Previous research has shown promise in enhancing autophagy as a therapeutic approach in neurodegenerative diseases, indicating potential for success in this area.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Chua, Jason Paul — Johns Hopkins University
- Study coordinator: Chua, Jason Paul
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.